Contraline: Series BDevelops hormonal and non-hormonal male contraceptives for men and couples globallyOct 4, 2026RoundOSContralineCompany profile and funding historySourcesbusinesswire.comMore in BiotechAusperBio · Series CProFound Therapeutics · StrategicTransfyr · SeedBiotechUnited StatesEnterprise softwareHealthtechNorth AmericaSeries B